PD-1 His-tagged Protein 8986-PD-100 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemPD-1 His-tagged Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $438.00Supplier Page View Company Product Page
Catalog Number8986-PD-100
ApplicationsBioactivity
Conjugate/TagUnconjugated
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Gene AliaseshPD-l, CD279, PD-1, PD1, hSLE1, SLEB2, hPD-1
NCBI Full Gene Nameprogrammed cell death 1
Source/Expression SystemHEK293-derived Recombinant Human PD-1 His Tagged Protein, CF
Molecule NamePD-1
SpeciesHuman
Molecular WeightObserved: 32 - 44 kDa, under reducing conditions.
Theoretical: 17 kDa
Purity>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining
FormatLyophilized from a 0.2 µm filtered solution in PBS
Size100 ug

Specifications/Features

Available conjugates: Sizes Available: 100 ug

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) The co-delivery of Programmed Death 1 ligands enhances and prolongs rAAV-mediated gene expression in pre-immunized miceGene TherapyJanuary 9, 2026Piia Käyhty, Tiina Nieminen, Reetta A. E. Eriksson, Ritva Tumelius, Ahmed Tawfek, Svetlana Laidinen, Anna-Kaisa Ruotsalainen, Aubrey Bailey, Lionel Galibert, Hanna P. Lesch, et al.HisPur Ni-NTA Magnetic Beads (Thermo Scientific). Lysates were collected, supplied with 2.5 µg of PD1-His (cat# 8986-PD-100, R&D Systems) recombinant protein, and incubated at 4 °C overnight. Controls were incubated without

(2) The RNA ligation method using modified splint DNAs significantly improves the efficiency of circular RNA synthesisAnimal Cells and SystemsDecember 11, 2023Yoon-Seob Kim, Do-Hyung Kim, Daegi An, Younghyun Lim, Young-Jin Seo, Hak Kyun Kim, Ho-Young KangImmuno Plate (Thermo, 436110) was coated with human recombinant PD-1 (1 ug/mL in PBS) (R&D systems, 8986-PD-100), then incubated overnight at 4°C. The next day, the plate was washed 3 times with 200 ul of washing

(3) Identification of the functional PD-L1 interface region responsible for PD-1 binding and initiation of PD-1 signalingThe Journal of biological chemistryDecember 1, 2023Carter R, Alanazi F, Sharp A, Roman J, Luchini A, Liotta L, Paige M, Brown AM, Haymond A.device. Dilutions of recombinant human PD-1 (2.5 μM, 625 nM, 156 nM, 40 nM) from R&D Systems (Cat. No. 8986-PD-100) were prepared in sterile PBS and allowed to flow over the chip at a flow rate of 50 μl/min. Traces

(4) Antibody-dependent cellular cytotoxicity-null effector developed using mammalian and plant GlycoDelete platformScientific reportsNovember 8, 2022Kang CE, Lee S, Ahn T, Seo DH, Ko BJ, Jung M, Lee J, Kim JY, Kim WT.MaxiSorp 96-well ELISA plate was coated with 10 ng/well (100 μL) of recombinant human PD-1 protein (#8986-PD-100, R&D Systems) at 4 °C overnight. A serial dilution of antibodies in PBS was incubated at 37 °C for 1

(5) Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody developmentScientific reportsOctober 22, 2022Phakham T, Boonkrai C, Wongtangprasert T, Audomsun T, Attakitbancha C, Saelao P, Muanwien P, Sooksai S, Hirankarn N, Pisitkun T.

(6) The multi-specific V_H-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activityBritish journal of cancerMay 1, 2022Edwards CJ, Sette A, Cox C, Di Fiore B, Wyre C, Sydoruk D, Yadin D, Hayes P, Stelter S, Bartlett PD, et al.

(7) Fenebrutinib in H₁ antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trialNature medicineNovember 1, 2021Metz M, Sussman G, Gagnon R, Staubach P, Tanus T, Yang WH, Lim JJ, Clarke HJ, Galanter J, Chinn LW, et al.

(8) Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapyPloS oneJanuary 1, 2021Issafras H, Fan S, Tseng CL, Cheng Y, Lin P, Xiao L, Huang YJ, Tu CH, Hsiao YC, Li M, et al.

(9) Reshaping nanobodies for affinity purification on protein aNew biotechnologyJuly 25, 2020Crauwels M, Van Vaerenbergh N, Kulaya NB, Vincke C, D'Huyvetter M, Devoogdt N, Muyldermans S, Xavier C.

(10) Assessing the binding properties of the anti-PD-1 antibody landscape using label-free biosensorsPloS oneJanuary 1, 2020Brown ME, Bedinger D, Lilov A, Rathanaswami P, Vásquez M, Durand S, Wallace-Moyer I, Zhong L, Nett JH, Burnina I, et al.

(11) Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCRmAbsJanuary 1, 2020Simons JF, Lim YW, Carter KP, Wagner EK, Wayham N, Adler AS, Johnson DS.portions of each target protein and were procured in a lyophilized form from either R&D Systems (PD-1, 8986-PD-100; PD-L1, 9049-B7-100) (Minneapolis, MN) or Acro Biosystems (CTLA-4, CT4-H5229; OX40, OX0-H5224) (Newark,

Be the First to Write a Review!

PD-1 His-tagged Protein

PD-1 His-tagged Protein

PD-1 His-tagged Protein

PD-1 His-tagged Protein

PD-1 His-tagged Protein from R&D Systems, a Bio-Techne Brand

Description

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (11)

Reviews

PD-1 His-tagged Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map